Human immunodeficiency virus type-1 episomal cDNA in semen

AIDS Research and Therapy

Volumn 2, Issue 1, 2005, Pages

  Xu, Chong ^a   Politch, Joseph A ^a   Mayer, Kenneth H ^b,c   Anderson, Deborah J ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b FENWAY INSTITUTE   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INDINAVIR; LAMIVUDINE; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; SAQUINAVIR; STAVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA EXTRACTION; DNA SEQUENCE; DRUG EXPOSURE; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; MALE; MALE GENITAL TRACT INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEMEN ANALYSIS; SOMATIC CELL; SOUTHERN BLOTTING; VIRUS DETECTION; VIRUS LOAD; VIRUS MUTATION;

EID: 33749034493     PISSN: 17426405     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-6405-2-9     Document Type: Article

References (36)

1. Anderson DJ, O'Brien TR, Politch JA, Martinez A, Seage GR, Padian N, Horsburgh CRJ, Mayer KH: Effects of disease stage and zidovudine therapy on the detection of human immunodeficiency virus type 1 in semen. Jama 1992, 267:2769-2774.
2. Pilcher CD, Tien HC, Eron JJJ, Vernazza PL, Leu SY, Stewart PW, Goh LE, Cohen MS: Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis 2004, 189:1785-1792.
3. Coombs RW, Reichelderfer PS, Landay AL: Recent observations on HIV type-1 infection in the genital tract of men and women. Aids 2003, 17:455-480.
4. Sadiq ST, Taylor S, Kaye S, Bennett J, Johnstone R, Byrne P, Copas AJ, Drake SM, Pillay D, Weller I: The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. Aids 2002, 16:219-225.
5. Vernazza PL, Gilliam BL, Dyer J, Fiscus SA, Eron JJ, Frank AC, Cohen MS: Quantification of HIV in semen: correlation with antiviral treatment and immune status. Aids 1997, 11:987-993.
6. Coombs RW, Speck CE, Hughes JP, Lee W, Sampoleo R, Ross SO, Dragavon J, Peterson G, Hooton TM, Collier AC, Corey L, Koutsky L, Krieger JN: Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998, 177:320-330.
7. Pillai SK, Good B, Pond SK, Wong JK, Strain MC, Richman DD, Smith DM: Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol 2005, 79:1734-1742.
8. Ping LH, Cohen MS, Hoffman I, Vernazza P, Seillier-Moiseiwitsch F, Chakraborty H, Kazembe P, Zimba D, Maida M, Fiscus SA, Eron JJ, Swanstrom R, Nelson JA: Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol 2000, 74:8946-8952.
9. Pudney J, Anderson DJ: Immunobiology of the human penile urethra. Am J Pathol 1995, 147: 155-165.
10. Porter E, Yang H, Yavagal S, Preza GC, Murillo O, Lima H, Greene S, Mahoozi L, Klein-Patel M, Diamond G, Gulati S, Ganz T, Rice PA, Quayle AJ: Distinct defensin profiles in Neisseria gonorrhoeae and Chlamydia trachomatis urethritis reveal novel epithelial cell-neutrophil interactions. Infect Immun 2005, 73:4823-4833.
11. Cohen MS: Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998, 351 Suppl 3:5-7.
12. Anderson DJ, Pudney J: Human male genital tract immunity and experimental models. In Mucosal Immunology Volume 2. 3rd edition. Edited by: Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR and Mayer L. New York, N.Y., Elsevier Academic Press; 2005:1647-1659.
13. Solas C, Lafeuillade A, Halfon P, Chadapaud S, Hittinger G, Lacarelle B: Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2003, 47:238-243.
14. Pauza CD, Trivedi P, McKechnie TS, Richman DD, Graziano FM: 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology 1994, 205:470-478.
15. Morlese J, Teo IA, Choi JW, Gazzard B, Shaunak S: Identification of two mutually exclusive groups after long-term monitoring of HIV DNA 2-LTR circle copy number in patients on HAART. Aids 2003, 17:679-683.
16. Sharkey ME, Teo I, Greenough T, Sharova. N, Luzuriaga K, Sullivan JL, Bucy RP, Kostrikis LG, Haase A, Veryard C, Davaro RE, Cheeseman SH, Daly JS, Bova C, Ellison RT, Mady B, Lai KK, Moyle G, Nelson M, Gazzard B, Shaunak S, Stevenson M: Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med 2000, 6:76-81.
17. Panther LA, Coombs RW, Zeh JE, Collier AC, Corey L: Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 17:303-313.
18. Zazzi M, Romano L, Catucci M, Venturi G, De Milito A, Almi P, Gonnelli A, Rubino M, Occhini U, Valensin PE: Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. J Med Virol 1997, 52:20-25.
19. Bushman F: Measuring covert HIV replication during HAART: the abundance of 2-LTR circles is not a reliable marker. Aids 2003, 17:749-750.
20. Butler SL, Johnson EP, Bushman FD: Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol 2002, 76:3739-3747.
21. Sharkey M, Triques K, Kuritzkes DR, Stevenson M: In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA. J Virol 2005, 79:5203-5210.
22. Dornadula G, Nunnari G, Vanella M, Roman J, Babinchak T, DeSimone J, Stern J, Braffman M, Zhang H, Pomerantz RJ: Human immunodeficiency virus type 1-infected persons with residual disease and virus reservoirs on suppressive highly active antiretroviral therapy can be stratified into relevant virologic and immunologic subgroups. J Infect Dis 2001, 183:1682-1687.
23. Mayer KH, Boswell S, Goldstein R, Lo W, Xu C, Tucker L, DePasquale MP, D'Aquila R, Anderson DJ: Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis 1999, 28:1252-1259.
24. Zhang H, Dornadula G, Beumont M, Livornese LJ, Van Uitert B, Henning K, Pomerantz RJ: Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998, 339:1803-1809.
25. Nunnari G, Otero M, Dornadula G, Vanella M, Zhang H, Frank I, Pomerantz RJ: Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without ongoing cellular infections. Aids 2002, 16:39-45.
26. Politch JA, Wolff H, Hill JA, Anderson DJ: Comparison of methods to enumerate white blood cells in semen. Fertil Steril 1993, 60:372-375.
27. Butler SL, Hansen MS, Bushman FD: A quantitative assay for HIV DNA integration in vivo. Nat Med 2001, 7:631-634.
28. Speck CE, Coombs RW, Koutsky LA, Zeh J, Ross SO, Hooton TM, Collier AC, Corey L, Cent A, Dragavon J, Lee W, Johnson EJ, Sampoleo RR, Krieger JN: Risk factors for HIV-1 shedding in semen. Am J Epidemiol 1999, 150:622-631.
29. Mostad SB, Kreiss JK, Ryncarz: A, Chohan B, Mandaliya K, Ndinya-Achola J, Bwayo JJ, Corey L: Cervical shedding of herpes simplex virus and cytomegalovirus throughout the menstrual cycle in women infected with human immunodeficiency virus type 1. Am J Obstet Gynecol 2000, 183:948-955.
30. Quayle AJ, Xu C, Mayer KH, Anderson DJ: T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 1997, 176:960-968.
31. Li HH, Gyllensten UB, Cui XF, Saiki RK, Erlich HA, Arnheim N: Amplification and analysis of DNA sequences in single human sperm and diploid cells. Nature 1988, 335:414-417.
32. Wolff H, Anderson DJ: Immunohistologic characterization and quantitation of leukocyte subpopulations in human semen. Fertil Steril 1988, 49:497-504.
33. Politch JA, Xu C, Tucker L, Anderson DJ: Separation of human immunodeficiency virus type 1 from motile sperm by the double tube gradient method versus other methods. Fertil Steril 2004, 81:440-447.
34. Pudney J, Anderson D: Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome. Am J Pathol 1991, 139:149-160.
35. Xu C, Politch JA, Tucker L, Mayer KH, Seage GR, Anderson DJ: Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J Infect Dis 1997, 176:941-947.
36. Paranjpe S, Craigo J, Patterson B, Ding M, Barroso P, Harrison L, Montelaro R, Gupta P: Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. AIDS Res Hum Retroviruses 2002, 18:1271-1280.